Literature DB >> 14579517

Glycine transporter isoforms in the mammalian central nervous system: structures, functions and therapeutic promises.

Jesus Gomeza1, Koji Ohno, Heinrich Betz.   

Abstract

The amino acid glycine (Gly) serves as a neurotransmitter at excitatory and inhibitory synapses in the mammalian central nervous system. Gly concentrations at post-synaptic neurotransmitter receptors are regulated by Na+/Cl(-)-dependent Gly transporters, which are expressed in neurons and in glial cells. Recent evidence suggests that these transporters are promising targets for the treatment of psychiatric and neurological disorders, such as schizophrenia and pain. Here, recent research on the structure, regulation and pharmacology of mammalian Gly transporters is reviewed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14579517

Source DB:  PubMed          Journal:  Curr Opin Drug Discov Devel        ISSN: 1367-6733


  12 in total

Review 1.  Molecular architecture of glycinergic synapses.

Authors:  Thomas Dresbach; Ralph Nawrotzki; Thomas Kremer; Stefanie Schumacher; Daniel Quinones; Martin Kluska; Jochen Kuhse; Joachim Kirsch
Journal:  Histochem Cell Biol       Date:  2008-08-22       Impact factor: 4.304

2.  Characteristics and regulation of glycine transport in Bergmann glia.

Authors:  Edith López; Irene Lee-Rivera; Ana María López-Colomé
Journal:  Neurochem Res       Date:  2005-12       Impact factor: 3.996

3.  Intact working memory in the absence of forebrain neuronal glycine transporter 1.

Authors:  Sylvain Dubroqua; Lucas Serrano; Detlev Boison; Joram Feldon; Pascual A Gargiulo; Benjamin K Yee
Journal:  Behav Brain Res       Date:  2012-02-08       Impact factor: 3.332

4.  Glycinergic Input to the Mouse Basal Forebrain Cholinergic Neurons.

Authors:  Zsuzsanna Bardóczi; Balázs Pál; Áron Kőszeghy; Tamás Wilheim; Masahiko Watanabe; László Záborszky; Zsolt Liposits; Imre Kalló
Journal:  J Neurosci       Date:  2017-09-05       Impact factor: 6.167

5.  A novel dominant hyperekplexia mutation Y705C alters trafficking and biochemical properties of the presynaptic glycine transporter GlyT2.

Authors:  Cecilio Giménez; Gonzalo Pérez-Siles; Jaime Martínez-Villarreal; Esther Arribas-González; Esperanza Jiménez; Enrique Núñez; Jaime de Juan-Sanz; Enrique Fernández-Sánchez; Noemí García-Tardón; Ignacio Ibáñez; Valeria Romanelli; Julián Nevado; Victoria M James; Maya Topf; Seo-Kyung Chung; Rhys H Thomas; Lourdes R Desviat; Carmen Aragón; Francisco Zafra; Mark I Rees; Pablo Lapunzina; Robert J Harvey; Beatriz López-Corcuera
Journal:  J Biol Chem       Date:  2012-06-29       Impact factor: 5.157

6.  Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat.

Authors:  Mark D Black; Geoffrey B Varty; Michal Arad; Segev Barak; Amaya De Levie; Denis Boulay; Philippe Pichat; Guy Griebel; Ina Weiner
Journal:  Psychopharmacology (Berl)       Date:  2008-08-16       Impact factor: 4.530

7.  SLC6A20 transporter: a novel regulator of brain glycine homeostasis and NMDAR function.

Authors:  Mihyun Bae; Junyeop Daniel Roh; Youjoung Kim; Seong Soon Kim; Hye Min Han; Esther Yang; Hyojin Kang; Suho Lee; Jin Yong Kim; Ryeonghwa Kang; Hwajin Jung; Taesun Yoo; Hyosang Kim; Doyoun Kim; Heejeong Oh; Sungwook Han; Dayeon Kim; Jinju Han; Yong Chul Bae; Hyun Kim; Sunjoo Ahn; Andrew M Chan; Daeyoup Lee; Jin Woo Kim; Eunjoon Kim
Journal:  EMBO Mol Med       Date:  2021-01-11       Impact factor: 12.137

8.  Glutamatergic targets for enhancing extinction learning in drug addiction.

Authors:  R M Cleva; J T Gass; J J Widholm; M F Olive
Journal:  Curr Neuropharmacol       Date:  2010-12       Impact factor: 7.363

9.  Glycine Receptors Caught between Genome and Proteome - Functional Implications of RNA Editing and Splicing.

Authors:  Pascal Legendre; Benjamin Förstera; Rene Jüttner; Jochen C Meier
Journal:  Front Mol Neurosci       Date:  2009-11-09       Impact factor: 5.639

10.  The astrocytic transporter SLC7A10 (Asc-1) mediates glycinergic inhibition of spinal cord motor neurons.

Authors:  Jeffrey T Ehmsen; Yong Liu; Yue Wang; Nikhil Paladugu; Anna E Johnson; Jeffrey D Rothstein; Sascha du Lac; Mark P Mattson; Ahmet Höke
Journal:  Sci Rep       Date:  2016-10-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.